Using cannabis for sleep isn’t harmless – it can trap people in a cycle of dependency
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepTHCSafetyMental HealthResearchDosingAnxiety Why This Matters Clinicians should understand that cannabis does not…
It may be legal for adults, but cannabis use a danger to young brains
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchPediatricsMental HealthSafetyNeurologyTHC Why This Matters Clinicians need to understand that legal adult…
Exilby Whole Plant Botanical Cannabis Treatment, Receives Marketing Authorization in Germany
✦ New CED Clinical Relevance#67 Notable Clinical InterestEmerging findings or policy developments worth monitoring closely. ResearchPolicyIndustrySafetyDosingTHCCBD Why This MattersThis approval establishes a regulated, standardized cannabis product with…
Avextra 10/10 Cannabis Extract in Sesame Linseed Oil Shows Promise
A Phase II randomized controlled trial evaluated Avextra 10/10 cannabis extract clinical trial for treating neurodegenerative diseases using a rigorous double-blind design. The study assessed both therapeutic benefits and safety profiles of this…
Can Cannabis Help Slow Alzheimer’s Disease? A Recent Study Says It Might – AOL
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyResearchAgingCBDTHCMental HealthSafety Why This Matters I need the complete article summary to provide an…
Avicanna Announces Closing of Non-Brokered Private Placement | Markets Insider
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBDTHCSafetyPolicyPain Clinical Summary Avicanna has completed a non-brokered private placement to fund…
Why Pharma Is Taking Cannabis Seriously – The Dales Report
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPolicyIndustryPainMental HealthCBDTHC Clinical Summary # Clinical Summary The pharmaceutical industry’s…
NIST Expands Mass Spectrometry Library to Improve Chemical Identification – Lab Manager
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyIndustryHempCBDTHCPain Why This Matters Clinicians need reliable analytical standards to distinguish…
Week in Weed – June 13, 2026 – StratCann
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBDTHCSafetyPolicyHemp Clinical Summary # Clinical Summary This article highlights advances in cannabis…
The United States just offically recliassified cannabis. The federal reclassification of medical …
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchTHCCBDIndustryDosingSafety Why This Matters Federal reclassification of cannabis from Schedule I to…